Jump Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Jump Financial's JAZZ Position: Q2 2026 in Review
Jump Financial opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2,700 shares worth $651K. The stake represents 0.01% of the portfolio and ranks #1369 among its holdings. This is a return to the name: Jump Financial previously reported a position in JAZZ as recently as Q1 2025.
Jump Financial first reported a position in JAZZ in Q4 2022 and has held it in 6 quarters since. The position peaked at $3.66M in Q4 2023. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Jump Financial held 2,700 shares of Jazz Pharmaceuticals worth $651K as of Q2 2026.
- Jazz Pharmaceuticals was a new Jump Financial position in Q2 2026.
- Jazz Pharmaceuticals made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1369 holding.
- Jump Financial first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 6 quarters since.
- Jump Financial's Jazz Pharmaceuticals position peaked at $3.66M in Q4 2023.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.